Infinity Pharmaceuticals, Inc.
INFIQ
Revenue
583.00k
▼-148.00k▼-20.25%
3 Months ChangeAssets
21.23M
▼-8.72M▼-29.11%
3 Months ChangeLiabilities
58.64M
▲365.00k▲0.6264%
3 Months ChangeFree Cash Flow
-12.58M
▲976.00k▲7.20%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2023-09-29
Form 8-K
ID: 0001113148-23-000018
2023-09-13
Form 8-K
ID: 0001113148-23-000016
2023-09-11
Form 8-K
ID: 0001113148-23-000014
2023-09-01
Form 8-K
ID: 0001113148-23-000012
2023-08-10
Form 10-Q
ID: 0001113148-23-000009
2023-07-25
Form 8-K
ID: 0001140361-23-036062
2023-07-24
Form 8-K
ID: 0001140361-23-035755
2023-07-14
Form 8-K
ID: 0001140361-23-034615
2023-07-03
Form 8-K
ID: 0001140361-23-032815
2023-06-30
Form 8-K
ID: 0001140361-23-032462